Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive

fluorodeoxyglucose f18 has been researched along with Supranuclear Palsy, Progressive in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19903 (5.26)18.7374
1990's6 (10.53)18.2507
2000's13 (22.81)29.6817
2010's26 (45.61)24.3611
2020's9 (15.79)2.80

Authors

AuthorsStudies
Eidelberg, D; Ležaić, L; Perovnik, M; Rebec, E; Rus, T; Studen, A; Tang, CC; Tomše, P; Trošt, M1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL1
Azulay, JP; Ceccaldi, M; Felician, O; Grimaldi, S; Guedj, E; Koric, L; Labouré, J; Pin, G1
Apostolova, I; Barthel, H; Berding, G; Brendel, M; Buchert, R; Buhmann, C; Dierks, A; Eidelberg, D; Höglinger, G; Huppertz, HJ; Katzdobler, S; Klietz, M; Levin, J; Mahmoudi, N; Rinscheid, A; Rogozinski, S; Rumpf, JJ; Sabri, O; Schneider, C; Spetsieris, PG; Stöcklein, S; Wattjes, MP; Wegner, F1
Blesa, R; Camacho, V; Fernández León, A; Lleó, A; López-Mora, DA1
Eidelberg, D; Grmek, M; Jensterle, L; Pirtošek, Z; Rus, T; Tang, C; Tomše, P; Trošt, M1
Gao, S; Li, X; Zhang, B; Zhao, P1
Berti, V; Cappa, SF; Catricalà, E; Conca, F; Esposito, V; Filippi, M; Gasparri, C; Iannaccone, S; Magnani, G; Perani, D; Polito, C; Presotto, L; Pupi, A; Sala, A; Sorbi, S1
Ali, F; Botha, H; Clark, HM; Duffy, JR; Josephs, KA; Lowe, VJ; Machulda, MM; Seckin, ZI; Strand, EA; Thu Pham, NT; Utianski, RL; Whitwell, JL1
Artiko, V; Brajkovic, L; Castiglioni, I; Gallivanone, F; Jecmenica-Lukic, M; Jesic, A; Kostic, V; Odalovic, S; Radovic, B; Sobic-Saranovic, D; Stefanova, E; Stojiljkovic, M; Trajkovic, G1
Eidelberg, D; Ge, J; Guan, Y; Ma, Y; Peng, S; Wang, J; Wu, J; Wu, P; Zhang, H; Zuo, C1
De Jong, BM; Dierckx, RA; Leenders, KL; Mudali, D; Renken, RJ; Roerdink, JB; Teune, LK1
Botha, H; Dickson, DW; Josephs, KA; Lowe, V; Whitwell, JL; Zalewski, N1
Amtage, F; Glauche, V; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, T; Tüscher, O; Weber, WA; Weiller, C; Winkler, C1
Amtage, F; Buchert, R; Guschlbauer, B; Hellwig, S; Meyer, PT; Niesen, WD; Reinhard, M; Tüscher, O; Weiller, C1
Amtage, F; Hellwig, S; Kreft, A; Maurer, C; Meyer, PT; Rijntjes, M; Tüscher, O; Weiller, C; Winkler, C1
Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Reid, RI; Schwarz, CG; Senjem, ML; Spychalla, AJ; Strand, EA; Whitwell, JL1
Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP1
Berlot, R; Kojović, M1
Amaral, LL; Barsottini, OG; Belezia, AB; Marussi, VH; Oliveira, AS; Pedroso, JL; Yared, J1
Amtage, F; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C1
Atkinson, R; Brooks, DJ; Edison, P; Fan, Z; Femminella, GD; Ninan, S1
Arighi, A; Bertram, K; Cioffi, SM; Colosimo, C; Fenoglio, C; Formica, A; Galimberti, D; Scarpini, E1
Ahn, JW; Choi, KU; Huh, GY; Jung, DS; Jung, NY; Kim, BK; Kim, EJ; Kim, SJ; Lee, JH; Lee, MJ; Lee, YM; Seeley, WW; Shin, JH; Shin, MJ; Sung, S1
Englund, E; Hansson, O; Honer, M; Nilsson, CF; Schöll, M; Smith, R1
Aigbirhio, FI; Allinson, KS; Arnold, R; Bevan-Jones, WR; Borchert, RJ; Cope, TE; Fryer, TD; Hong, YT; Jones, PS; Mak, E; O'Brien, JT; Passamonti, L; Rowe, JB; Sami, S; Su, L; Surendranathan, A; Vázquez Rodríguez, P; Williamson, D1
Chung, SJ; Im, KC; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Oh, SJ; Park, HK1
Castelnovo, G; Collombier, L; Labauge, P; Renard, D1
Go, SM; Kim, EJ; Na, DL; Roh, JH; Seo, SW; Suh, MK1
Bartenstein, P; Brandt, T; Deutschenbaur, L; Dieterich, M; Jahn, K; Krafczyk, S; la Fougère, C; Linn, J; Lorenzl, S; Rominger, A; Strupp, M; Xiong, G; Zwergal, A1
Lewitt, PA; Sidiropoulos, C1
Gao, S; Zhang, B; Zhao, P1
Bauer, S; Berg, D; Dietzel, E; Liepelt-Scarfone, I; Liscic, RM; Maetzler, W; Reimold, M; Srulijes, K1
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH1
Guo, XJ; Li, DC; Ma, AJ; Pan, XD; Zhang, BS1
Bartenstein, P; Brandt, T; Deutschenbaur, L; Dieterich, M; Jahn, K; la Fougère, C; Linn, J; Lorenzl, S; Rominger, A; Schöberl, F; Strupp, M; Xiong, G; Zwergal, A1
Brooks, DJ; Chaudhuri, KR; Hu, MT; Jarosz, J; Yaguez, L1
Ishii, K; Ishiwata, K; Katayama, Y; Kitamura, S; Kobayashi, S; Mishina, M; Mitani, K; Ohyama, M; Senda, M; Yamazaki, M1
Choe, B; Juh, R; Kim, J; Moon, D; Suh, T1
Arai, H; Furukawa, Y; Hamaguchi, T; Ihara, Y; Ishida, C; Katayama, S; Kawakami, A; Kitamoto, T; Kohriyama, T; Kuji, I; Kuroda, S; Maruyama, M; Mitani, K; Mizusawa, H; Murayama, S; Nakamura, Y; Nishinaka, T; Noguchi, M; Sato, T; Shiga, Y; Suzuki, N; Udaka, F; Yamada, M; Yamamoto, T; Yamashita, M1
de Jong, BM; de Vries, JJ; Klein, RC; Leenders, KL1
Barnes, A; Dhawan, V; Eckert, T; Eidelberg, D; Feigin, AS; Frucht, S; Gordon, MF1
Brown, N; Eckert, T; Eidelberg, D; Feigin, A; Frucht, S; Lin, T; Ma, Y; Tang, C1
Ishii, K; Jamzad, M; Senda, M; Toyama, H1
Otsuka, M; Taniwaki, T1
Brooks, WS; Creasey, H; Fulham, MJ; Halliday, GM; Kwok, JB; Morris, JG; Schofield, PR; Stanford, PM; Storey, CE1
Foster, NL; Gilman, S; Heumann, ML; Johanns, J; Kuhl, DE; Little, R; Minoshima, S1
Degueldre, C; Destée, A; Franck, G; Garraux, G; Kreisler, A; Lemaire, C; Peigneux, P; Salmon, E1
Brooks, DJ; Ceravolo, R; de Yebenez, J; Lees, AJ; Piccini, P; Pramstaller, P; Turjanski, N1
Hirono, N; Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M1
Berent, S; D'Amato, C; Foster, NL; Gilman, S; Hicks, SP; Koeppe, RA; Sima, AA1
Grond, M; Heiss, WD; Herholz, K; Huber, M; Karbe, H; Kessler, J1
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K1
Kato, M1
Bol, A; Cogneau, M; De Volder, AG; Gillain, C; Goffinet, AM; Labar, D; Laterre, C; Michel, C; Rectem, D1
Berent, S; Brown, MB; Foster, NL; Gilman, S; Koeppe, RA; Morin, EM1
Hanson, WR; Metter, EJ1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive

ArticleYear
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
    Neurology, 2005, Feb-22, Volume: 64, Issue:4

    Topics: 14-3-3 Proteins; Age of Onset; Aged; Alzheimer Disease; Biomarkers; Blotting, Western; Cerebral Cortex; Cerebrospinal Fluid Proteins; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Prions; Supranuclear Palsy, Progressive; Thalamus; Tomography, Emission-Computed, Single-Photon

2005
[Functional imaging for disorders of basal ganglia].
    Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:1

    Topics: Basal Ganglia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1999

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive

ArticleYear
Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy.
    Acta neurologica Scandinavica, 2004, Volume: 110, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mesencephalon; Middle Aged; Radiopharmaceuticals; Regression Analysis; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2004
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Journal of the neurological sciences, 2002, Jul-15, Volume: 199, Issue:1-2

    Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2002

Other Studies

53 other study(ies) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive

ArticleYear
Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2022, Volume: 98

    Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Parkinsonism & related disorders, 2022, Volume: 101

    Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
Brain FDG-PET correlates of saccadic disorders in early PSP.
    Journal of neurology, 2023, Volume: 270, Issue:10

    Topics: Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies; Saccades; Supranuclear Palsy, Progressive

2023
Automatic covariance pattern analysis outperforms visual reading of
    Movement disorders : official journal of the Movement Disorder Society, 2023, Volume: 38, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Movement Disorders; Positron-Emission Tomography; Retrospective Studies; Supranuclear Palsy, Progressive

2023
The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:5

    Topics: Aged; Aminopyridines; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Quinolines; Supranuclear Palsy, Progressive; tau Proteins

2020
Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns' based approach.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12

    Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2020
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 80

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Supranuclear Palsy, Progressive

2020
Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study.
    Neurology, 2020, 11-17, Volume: 95, Issue:20

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Connectome; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Language; Male; Neurodegenerative Diseases; Occipital Lobe; Pattern Recognition, Visual; Positron-Emission Tomography; Retrospective Studies; Semantics; Speech; Supranuclear Palsy, Progressive; Temporal Lobe

2020
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Parkinsonism & related disorders, 2020, Volume: 81

    Topics: Aged; Apraxias; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Hypokinesia; Language Tests; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Positron-Emission Tomography; Postural Balance; Radiopharmaceuticals; Speech Disorders; Supranuclear Palsy, Progressive; Tremor

2020
The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Neurological research, 2017, Volume: 39, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2017
Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Human brain mapping, 2018, Volume: 39, Issue:7

    Topics: Aged; Brain; Brain Mapping; China; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; United States

2018
Validation of parkinsonian disease-related metabolic brain patterns.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:4

    Topics: Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive

2013
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.
    Journal of neurology, 2014, Volume: 261, Issue:4

    Topics: Age of Onset; Aged; Aged, 80 and over; Autopsy; Brain Chemistry; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroglia; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tauopathies

2014
Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:4

    Topics: Aged; Aged, 80 and over; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Neurons; Positron-Emission Tomography; Prognosis; Supranuclear Palsy, Progressive

2014
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    European journal of neurology, 2014, Volume: 21, Issue:6

    Topics: Aged; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Radionuclide Imaging; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Ultrasonography, Doppler, Transcranial

2014
Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study.
    Parkinsonism & related disorders, 2014, Volume: 20, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ocular Motility Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2014
The evolution of primary progressive apraxia of speech.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 10

    Topics: Age of Onset; Aged; Brain; Cognition; Diffusion Tensor Imaging; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Speech; Speech Disorders; Supranuclear Palsy, Progressive

2014
A disease-specific metabolic brain network associated with corticobasal degeneration.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 11

    Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive

2014
Palatal tremor in progressive supranuclear palsy: a case report.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:3

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mesencephalon; Palate; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tremor

2015
PET-CT imaging in a patient with progressive supranuclear palsy.
    Arquivos de neuro-psiquiatria, 2015, Volume: 73, Issue:4

    Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2015
18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:10

    Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lewy Body Disease; Male; Middle Aged; Movement Disorders; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Survival Analysis

2015
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    Journal of Alzheimer's disease : JAD, 2016, Volume: 51, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antineoplastic Agents; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Neurons; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive

2016
Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.
    Journal of Alzheimer's disease : JAD, 2016, 05-04, Volume: 53, Issue:2

    Topics: Aged; Aged, 80 and over; Brain Diseases; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Genotype; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation; Positron-Emission Tomography; Progranulins; Supranuclear Palsy, Progressive

2016
An autopsy confirmed case of progressive supranuclear palsy with predominant cerebellar ataxia.
    Journal of neurology, 2016, Volume: 263, Issue:12

    Topics: Autopsy; Brain; Cerebellar Ataxia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Supranuclear Palsy, Progressive

2016
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.
    Acta neuropathologica, 2017, Volume: 133, Issue:1

    Topics: Aged; Brain; Carbolines; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins

2017
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Brain : a journal of neurology, 2017, 03-01, Volume: 140, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Autoradiography; Brain; Carbolines; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Protein Binding; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive; tau Proteins

2017
Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-30, Volume: 24, Issue:2

    Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glucose; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tropanes

2009
Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
    Neurology, 2010, Apr-06, Volume: 74, Issue:14

    Topics: Accidental Falls; Aged; Atrophy; Biomarkers; Brain; Deglutition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mesencephalon; Ocular Motility Disorders; Personality Disorders; Positron-Emission Tomography; Predictive Value of Tests; Supranuclear Palsy, Progressive

2010
Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism.
    Neurology, 2010, Sep-14, Volume: 75, Issue:11

    Topics: Aged; Basal Ganglia Diseases; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive

2010
Postural imbalance and falls in PSP correlate with functional pathology of the thalamus.
    Neurology, 2011, Jul-12, Volume: 77, Issue:2

    Topics: Accidental Falls; Aged; Brain Mapping; Disability Evaluation; Eye; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Postural Balance; Rest; Statistics as Topic; Supranuclear Palsy, Progressive; Thalamus

2011
Localizing imbalance in progressive supranuclear palsy: is the thalamus the "fall guy"?
    Neurology, 2011, Jul-12, Volume: 77, Issue:2

    Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Radionuclide Imaging; Supranuclear Palsy, Progressive; Thalamus

2011
18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Parkinsonism & related disorders, 2012, Volume: 18 Suppl 1

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Syndrome

2012
Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:1

    Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; ROC Curve; Severity of Illness Index; Supranuclear Palsy, Progressive; Thalamus

2012
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Neurology, 2012, Sep-25, Volume: 79, Issue:13

    Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2012
[A study on the cerebral glucose metabolism in progressive supranuclear palsy].
    Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:11

    Topics: Aged; Brain; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive

2012
Functional disturbance of the locomotor network in progressive supranuclear palsy.
    Neurology, 2013, Feb-12, Volume: 80, Issue:7

    Topics: Aged; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Locomotion; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Prospective Studies; Rest; Severity of Illness Index; Supranuclear Palsy, Progressive

2013
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Adult; Aged; Black People; Brain; Cerebral Cortex; Corpus Striatum; Cross-Cultural Comparison; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; India; Lewy Body Disease; London; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinsonian Disorders; Radiography; Radionuclide Imaging; Supranuclear Palsy, Progressive; West Indies; White People

2002
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    European journal of radiology, 2004, Volume: 51, Issue:3

    Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mesencephalon; Middle Aged; Multiple System Atrophy; Neocortex; Parkinson Disease; Parkinsonian Disorders; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive; Thalamus

2004
Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:8

    Topics: Aged; Blood Glucose; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Regional Blood Flow; Supranuclear Palsy, Progressive

2005
FDG PET in the differential diagnosis of parkinsonian disorders.
    NeuroImage, 2005, Jul-01, Volume: 26, Issue:3

    Topics: Aged; Aging; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2005
Abnormal metabolic networks in atypical parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5

    Topics: Aged; Brain Stem; Cerebellum; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Reference Values; Reproducibility of Results; Supranuclear Palsy, Progressive

2008
A human friendly reporting and database system for brain PET analysis.
    Annals of nuclear medicine, 1996, Volume: 10, Issue:1

    Topics: Alzheimer Disease; Brain; Brain Diseases; Computer Graphics; Computer Systems; Data Interpretation, Statistical; Databases, Factual; Deoxyglucose; Epilepsy, Temporal Lobe; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed

1996
Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
    Brain : a journal of neurology, 2000, Volume: 123 ( Pt 5)

    Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia; Base Sequence; Brain; Child; Chromosomes, Human, Pair 17; Dinucleotide Repeats; Exons; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurofibrillary Tangles; Pedigree; Phenotype; Polymorphism, Genetic; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins; Tomography, Emission-Computed

2000
PET measures of benzodiazepine receptors in progressive supranuclear palsy.
    Neurology, 2000, May-09, Volume: 54, Issue:9

    Topics: Aged; Aged, 80 and over; Blood Glucose; Brain; Brain Mapping; Female; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Gyrus Cinguli; Humans; Male; Middle Aged; Predictive Value of Tests; Receptors, GABA-A; Reference Values; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2000
Voxel-based distribution of metabolic impairment in corticobasal degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Blood Glucose; Brain; Brain Diseases, Metabolic; Case-Control Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Neurodegenerative Diseases; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2000
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
    Archives of neurology, 2001, Volume: 58, Issue:11

    Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Pedigree; Putamen; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2001
Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:8

    Topics: Blood Glucose; Brain; Deoxyglucose; Diagnosis, Differential; Energy Metabolism; Fluorodeoxyglucose F18; Gliosis; Humans; Neurofibrillary Tangles; Neurologic Examination; Neuropsychological Tests; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
    Journal of neurology, 1992, Volume: 239, Issue:2

    Topics: Aged; Basal Ganglia; Cerebral Cortex; Deoxyglucose; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Mesencephalon; Middle Aged; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
Positron emission tomography in degenerative disorders of the dopaminergic system.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2

    Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
[Positron emission tomography and basal ganglia functions].
    No to shinkei = Brain and nerve, 1990, Volume: 42, Issue:5

    Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Deoxyglucose; Dopamine; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Macaca mulatta; Mice; Parkinson Disease; Rats; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1990
Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
    Annals of neurology, 1989, Volume: 25, Issue:2

    Topics: Aged; Autoradiography; Blood Glucose; Brain Mapping; Deoxyglucose; Dominance, Cerebral; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Neuropsychological Tests; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1989
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Annals of neurology, 1988, Volume: 24, Issue:3

    Topics: Aged; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Organ Specificity; Reference Values; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1988
Clinical and acoustical variability in hypokinetic dysarthria.
    Journal of communication disorders, 1986, Volume: 19, Issue:5

    Topics: Aged; Deoxyglucose; Dysarthria; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phonation; Radioisotopes; Speech; Speech Acoustics; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1986